Neurological disease drug developer Axial raised $37.3m from investors including Taiho Ventures while Best Buy is purchasing OSF and Legal & General-backed remote healthcare technology provider Current Health.
Funding
US-based neurological disease therapy developer Axial Therapeutics closed a $37.3m series C round yesterday featuring Taiho Ventures, the investment arm of pharmaceutical firm Taiho. The round was co-led by OneVentures and University of Tokyo’s Innovation Platform Company and included Autism Impact Fund, Corundum Systems Biology, Longwood Fund, Seventure Partners and Domain Associates. Axial has now raised $91.5m in total, Taiho Ventures having put up $10m to close a series B round featuring care provider Heritage Medical Systems, Health for…
